Kempten, Germany

Rene Wodrich

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Kennametal Inc.. Active years: 2014.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Rene Wodrich

Introduction

Rene Wodrich is a notable inventor based in Kempten, Germany. She has made significant contributions to the field of electrochemical treatment, showcasing her expertise through her innovative patent.

Latest Patents

Wodrich holds a patent for a "Device and method for electrochemical treatment." This invention relates to a method and device designed for the electrochemical treatment of at least one component. The device features a treatment chamber, at least one feed unit for an electrolyte, and a mechanism for adjusting the pH value of the electrolyte prior to its introduction into the treatment chamber. This innovation highlights her commitment to advancing technology in this area.

Career Highlights

Throughout her career, Rene Wodrich has worked with several prominent companies, including Kennametal Inc. and WME Gesellschaft für Windkraftbetriebene Meerwasserentsalzung mbH. Her experience in these organizations has allowed her to develop and refine her skills in the field of electrochemical treatment.

Collaborations

Wodrich has collaborated with notable individuals such as Rainer Huss and Patrick Matt. These partnerships have contributed to her growth as an inventor and have facilitated the development of her innovative ideas.

Conclusion

Rene Wodrich's contributions to the field of electrochemical treatment through her patent and professional collaborations demonstrate her significant impact as an inventor. Her work continues to inspire advancements in technology and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…